Clinical trial Recruiting at 1 site Observational Ages 18 to 90

GERD patient registry study using a large prospective clinical database

Official title: Establishing an Innovative Cohort of Chinese Patients With Gastroesophageal Reflux Disease Based on the Prospective Database of the National Clinical Research Center for Digestive Diseases: A Retrospective Study

Run by Beijing Friendship Hospital · NCT07749989 · Data updated 2026-11-12

A large group of adults with gastroesophageal reflux disease are being looked at in real-world care to see who they are, what treatments they get, and how symptoms and well-being change after treatment.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment5000 (estimated)
SponsorBeijing Friendship Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedApril 17, 2026
Main results expectedApril 2027
Study endsMay 2027
Registry record updatedAugust 6, 2026
Trial IDNCT07749989 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to 90 with a confirmed GERD diagnosis who were evaluated and treated at Beijing Friendship Hospital and consent to use of their data.

Probably not a fit

Patients with incomplete data, uncertain GERD diagnosis, or those who do not consent may not benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational analysis using data from a prospective registry to describe demographics, clinical features, psychological status, and treatment patterns of GERD patients in China. Researchers will retrospectively extract baseline and follow-up data, including diagnostic findings, preoperative psychology, surgical outcomes, and symptom changes after treatment. The goal is to understand real-world care and post-treatment quality of life in a large cohort. The study leverages data from Beijing Friendship Hospital and uses clinical information for future research.

Why it matters

Potential benefit: If successful, insights could inform patient care pathways and improve understanding of how treatments affect GERD symptoms and psychological well-being in real-world settings.

How similar studies have gone: Previous real-world data analyses of GERD have provided meaningful insights into treatment patterns and outcomes, supporting the value of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 and 90 years old.
* Patients were required to present with at least one typical symptom of gastroesophageal reflux disease (GERD)-such as heartburn, regurgitation, or non-cardiac chest pain-and to have presented to Beijing Friendship Hospital for the evaluation and management of these symptoms.
* Received treatment, including pharmacological therapy and anti-reflux surgery, at Beijing Friendship Hospital.
* Voluntary signing of informed consent, agreeing to the use of clinical information for future research.

Exclusion Criteria:

* Female patients who were pregnant or lactating.
* Patients with significantly incomplete or missing critical clinical data.
* Patients with an equivocal or unconfirmed diagnosis of GERD.
* Current neurologic or cognitive impairment, which would preclude ability to obtain informed consent.
* Refusal to participate in the study.

Where it's running

  • Beijing Friendship Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.